Real-time enrollment status for this heart attack clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:22 PM UTC
| NCT Number | NCT06118281 |
| Recruiting Status | Recruiting |
| Condition | Heart Attack |
| Phase | PHASE3 |
| Target Enrollment | 10,000 participants |
| Active Locations | 208 sites in the US |
| Sponsor | Novo Nordisk A/S |
| Last Updated on CT.gov | April 14, 2026 (Apr 14, 2026) |
As of July 18, 2026: Clinical trial NCT06118281 is currently recruiting participants. This phase3 study for heart attack is actively seeking new participants at 208 locations across the United States. The study is sponsored by Novo Nordisk A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06118281 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 208 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06118281 was last updated Apr 14, 2026 (April 14, 2026). HelloStudys verifies this status automatically.